| HOME >> BIOLOGY >> TECHNOLOGY |
BETHESDA, Md., April 15 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the acquisition of Envision Pharma, a leading scientific communications and technology company based in Horsham, UK, with offices in Southport and Glastonbury, Conn. and Philadelphia, Pa. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications that contribute to marketplace awareness and comprehension of compounds at launch and beyond.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )
UBC provides evidence-based solutions to support the development and commercialization of pharmaceuticals, biotechnology and medical devices. The acquisition of Envision Pharma expands the company's global presence and capability in the development and delivery of scientific communication.
Envision Pharma has two market-leading applications. Datavision(TM) is the pharmaceutical industry's premier application for developing and managing transparent, compliant publications programs. Used by over 30 companies with nearly 400 products, Datavision(TM) provides a platform for strategic planning and workflow management, while ensuring compliance and precision in the publications process. Visiontracker(TM), launched in 2007, offers management of independent investigator trials, supporting the process from application through to study completion for both the investigator and sponsor.
Envision Pharma combines its publications technology software with a
global staff of experienced medical writers to support the planning and
development of medical publications and other scientific communications for
its pharmaceutical clients. The team also provides publication consultancy
services to the industry, including the development of policies and
processes that ensure optimal legislative a
'/>"/>
| SOURCE United BioSource Corporation Copyright©2008 PR Newswire. All rights reserved |